GLD vs ZBIO
SPDR® Gold Shares (GLD) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
SPDR® Gold Shares (GLD) common stock listed on NYSE ARCA.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
GLD does not have a complete income-statement cache yet.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
GLD currently screens at market cap $0. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the GLD and ZBIO stock pages for the full models.
Not investment advice.